Higher Level Practitioner Development: A Way Forward in the South East BOPA Symposium 2007 Michael...
-
Upload
cody-lloyd -
Category
Documents
-
view
214 -
download
0
Transcript of Higher Level Practitioner Development: A Way Forward in the South East BOPA Symposium 2007 Michael...
Higher Level Practitioner Development: A Way
Forward in the South East
BOPA Symposium 2007
Michael PowellLead Pharmacist
Mount Vernon Cancer Network
Aims
• To outline the function of the Joint Programme Board
• To describe the pharmacy practitioner development strategy as it relates to higher level practice
• To describe current and likely future developments in higher level practice in the South East. How might these be relevant to oncology pharmacy practice?
Why reform post-registration education?
• No systematic provision of post grad education for pharmacy practitioners.
• Level of current provision evolved in somewhat haphazard way from the need for a level of clinical pharmacist skills and knowledge not catered for by undergrad/pre-reg curricula
Why reform post-registration education?
• Foster Report (July 2006):– Re-emphasises the need for competence
linked with performance assessment– Emphasises the need for re-validation:
• Ongoing evaluation of an individual’s fitness to practice
• Must be both formative and summative
Department of Health. The regulation of the non-medical healthcare professions. A review by the Department of Health. July 2006.
What is the JPB?
Collaboration
Educational Quality
Academia (SOPs) Brighton KCL Medway Portsmouth London UEA
NHSSpecialist ServicesSpecialist groupsSenior Managers
Service Perspective
Key JPB Responsibilities
• Develop uniform & coherent curricula for general and advanced practice
• Develop tutor training courses to support work-based learning
• Design reliable, fair & appropriate assessments• Undertake the accreditation of training centres• Build systems for on-going QA of E&T systems• Assign academic credits to programmes as
appropriate• Issue statements of completion of training at
general & advanced levels.
To Date – Generalist Training Band 6 (3 years)
• PG Diploma in General Pharmacy Practice (MI, Technical, Patient & Clinical Services plus “tasters” of specialist areas)
• Validated by 5 of the JPB HEI’s
• Statement of completion of general training
• Currently 200 practitioners/students across the south-east
JPB as a supportive infrastructure
Training Centres(Gen + Specialist)Directors PharmacyEducation(Trust/Pan-TrustRoles)
Post-RegistrationPharmacy
Joint Programmes Board
The NHSSPMs,
Training Centres,Specialist Pharmacy
Services
HEIs
The NHSPharmacy
SIGs?
Developing the infrastructure – key principles
• Work-based learning
• Resources practice tutors
• Assesses competence and performance
• Systems for dealing with poor performance
• Standardises approaches across specialties
Undergraduate & Pre-registration Phases
Consultant Practitioner
General Level
Framework
Higher Level Framework: Advanced
& Consultant
General Level
Development Phase
Higher Level Development Phase 1
Higher Level Development Phase 2
General Level Practitioner
Advanced Practitioner
PG enabling programmes
General Diploma
Masters Adv Practice
Research Degree
Training infrastructure support Higher Level Practice System
JPB(Regional e.g. South East England)
Training Centres•Single Trusts or collaboratives – across health sectors
•Accredited to deliver training at Generalist, Higher Level or both•Internal QA systems
•Manage tutee experiences
Practitioner Development Strategy
• Imperative to recognise formally that there are different levels of practice:– complex & diverse nature of
pharmacist roles– Clinical governance– Impact of AfC
D Webb et al. Hosp Pharm Mar 2004; 11: 104-109
Practitioner Development Strategy
• Different levels of practice must capture:– Clinical pharmacy specialisation (e.g.
oncology)– Expertise in other disciplines (e.g. MI, tech
services)
• Should be sector independent:– Should encompass pharmacy practitioners
within 1°/2° care and community pharmacy
D Webb et al. Hosp Pharm Mar 2004; 11: 104-109
JPB & Higher Level Practice
• Focus now on developing strategy for higher level practitioner development
• Scoping meetings held in London in January and May 2007
• Key themes:– Consistency– Overcoming silo mentality– Identifying barriers– Overcoming barriers– System of representation– Collaborations with HEIs– Time frames– Duality of award– Titles
Practitioner development strategy: Alignment with AfC
Consultant Practitioner
Higher Level Framework: Advanced
& Consultant
Higher Level Development Phase 1
Higher Level Development Phase 2
Undergraduate & Pre-registration Phases
General Level
Framework
General Level
Development Phase
Advanced Practitioner
General Level Practitioner
Band 6 (3yrs)
Band 7 – 8a(3-5yrs)
Band 8 b-d(3 yrs)
Advanced & Consultant Level Framework (ACLF)
• 34 competencies in 6 clusters:– Expert professional practice (EPP)– Building working relationships (BR)– Leadership (L)– Management (M)– Education, training & development (ETD)– Research & evaluation (RE)
• Each competency has 3 levels of attainment: Foundation, excellence & mastery
• In England, describes the competency profiles expected of applicants for consultant pharmacist posts
Competency Profiles
• Consultant profile– EPP, BR and L at
Mastery– M, ETD and RE at
Excellence• Advanced profile
– 5 clusters at Excellence– RE at Foundation
• PhwSI profile– 4 clusters at Excellence– 2 clusters ETD, RE
optional
JPB – some key facts
• JPB does not influence Specialist Group alliances or relationships
• JPB is a system for discharging the curriculum – which belongs to the specialist group
• JPB is an inclusive system – engages all SGs and all HEIs – promotes local relationships rather than aligning with one HEI.
• Research commitment to final aspect (8b-d) requires local HEI engagement
• Encourages all SGs to collaborate to standardise the output across specialities
• JPBs must maintain a geographical relationship which builds on existing and historical networks.
Accreditation
• Clear recognition that JPB should work with specialist groups such as BOPA to:– Design the curricula for general & advanced
level practice– Design appropriate assessment methods to
meet the learning outcomes associated with general & advanced practice
• Assessment of portfolio of evidence• Viva
Latest Developments with the JPB
Dr Catherine Duggan
Associate Director of Clinical Pharmacy for Evaluation and Development &
Senior Clinical LecturerLondon, Eastern and South East NHS and School of Pharmacy,
University of London
Further reading
• Key literature on practitioner development:– Davies et al. Hosp Pharm Jan 04; 11: 2– Webb et al. Hosp Pharm Mar 04; 11: 104-109– Bates et al. Pharm J Mar 04; 272: 283
• Websites for further info:– JPB: www.postgraduatepharmacy.org– CoDEG: www.codeg.org